NCT04947098

Brief Summary

Prevent Cancer-Greenville was created to provide individuals with the opportunity to have their risk of developing cancer studied. Some individuals may be at a higher risk due to their personal lifestyle, family history and/or exposures. If subjects are found to be at high risk for developing a disease, they will be sent to a healthcare provider for further care.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
43mo left

Started Nov 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Nov 2018Nov 2029

Study Start

First participant enrolled

November 8, 2018

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

April 29, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 1, 2021

Completed
7.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 8, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 8, 2029

Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

10 years

First QC Date

April 29, 2021

Last Update Submit

February 11, 2026

Conditions

Outcome Measures

Primary Outcomes (10)

  • Assess changes in nutrition by nutrition questionnaire

    Nutrition will be assessed yearly by a questionnaire based on nutrition recommendations from the American Institute for Cancer Research and the U.S. Department of Health and Human Services.

    Yearly follow up for 10 years

  • Assess changes in physical activity by physical activity questionnaire

    Physical activity will be assessed yearly a questionnaire based on physical activity recommendations from the U.S. Department of Health and Human Services.

    Yearly follow up for 10 years

  • Assess changes in smoking habits

    Participants will be educated on healthy lifestyle habits and smoking habits will be assessed yearly.

    Yearly follow up for 10 years

  • Assess changes in alcohol use

    Participants will be educated on healthy lifestyle habits and alcohol use will be assessed yearly.

    Yearly follow up for 10 years

  • Assess hereditary risk through family history review

    Each participant's family history will be reviewed to make recommendations for screening or genetic testing based on National Comprehensive Cancer Network guidelines.

    Yearly follow up for 10 years

  • Assess lifetime breast cancer risk through the Tyrer-Cuzick version 8 breast risk evaluation tool

    Participants' breast cancer risk will be assessed using the Tyrer-Cuzick breast cancer risk model. Participants will be referred to appropriate clinics if lifetime risk is greater than 20 percent.

    Yearly follow up for 10 years

  • Assess 5- year breast cancer risk through the GAIL breast risk evaluation tool

    Participants' breast cancer risk will be assessed using the National Cancer Institute's GAIL model. Participants will be referred to appropriate clinics if GAIL 5 year risk is greater than 1.7 percent.

    Yearly follow up for 10 years

  • Early detection of malignancies through screening

    Participants will be educated on screening recommendations by the American Cancer Society. Malignancies will be recorded yearly if found by recommended screenings.

    Yearly follow up for 10 years

  • Assess changes in fat mass by SOZO measurements

    Body composition will be assessed yearly by measurements taken from the SOZO device which uses bioimpedance spectroscopy to measure fat mass.

    Yearly follow up for 10 years

  • Assess changes in muscle mass by SOZO measurements

    Body composition will be assessed yearly by measurements taken from the SOZO device which uses bioimpedance spectroscopy to measure muscle mass.

    Yearly follow up for 10 years

Secondary Outcomes (1)

  • Assess changes in quality of life by the 5-level EuroQol-5D version (EQ-5D-5L) questionnaire

    Yearly follow up for 10 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals 18 years or older

You may qualify if:

  • years or older

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prisma Health-Upstate

Greenville, South Carolina, 29605, United States

RECRUITING

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Blood, urine and cheek swab specimens will be collected.

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Joe Stephenson, MD

    Prisma Health-Upstate

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Patricia Wilson, MSN Ed. OCN ONNCG

CONTACT

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 29, 2021

First Posted

July 1, 2021

Study Start

November 8, 2018

Primary Completion (Estimated)

November 8, 2028

Study Completion (Estimated)

November 8, 2029

Last Updated

February 17, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

De-identified data sets will be available upon requests following institutional approval.

Shared Documents
STUDY PROTOCOL, ICF, CSR

Locations